Bloom G D, Carlsöö B, Danielsson A, Domeij S, Henriksson R
Med Biol. 1983;61(6):305-12.
Administration of the selective beta 1-adrenoceptor agonist, prenalterol, affects the acinar cell of the rat parotid in a manner similar to that observed after isoprenaline (IPR) treatment. Sixty minutes after injection of prenalterol, many cells are depleted of their zymogen granules and there is evidence of secretory protein resynthesis. Long term treatment leads to cellular hypertrophy and marked structural changes in the granule population. The cellular alterations are, however, not as pronounced as those observed after IPR injections. This may be due to the combined beta 1- and beta 2-adrenoceptor effect of IPR. With prenalterol, cell damage is obvious in acute experiments. In long term treated animals numerous characteristic autophagic vacuoles are observed, reflecting a reorganization of cytoplasmic components in superstimulated glands. Although prenalterol and IPR give rise to rather similar structural changes in parotid glands, marked differences between effects of the two drugs on gland biochemistry have been noted. It seems evident that different biochemical pathways involved in secretory activity have actions in common with respect to effects on submicroscopical structures.
给予选择性β1 - 肾上腺素能受体激动剂普瑞特罗,对大鼠腮腺腺泡细胞的影响方式与注射异丙肾上腺素(IPR)后观察到的相似。注射普瑞特罗60分钟后,许多细胞的酶原颗粒减少,并有分泌蛋白重新合成的迹象。长期治疗会导致细胞肥大以及颗粒群体的明显结构变化。然而,细胞改变不如IPR注射后观察到的那么明显。这可能是由于IPR具有β1和β2肾上腺素能受体的联合效应。在急性实验中,普瑞特罗会导致明显的细胞损伤。在长期治疗的动物中,观察到大量特征性的自噬泡,这反映了超刺激腺体中细胞质成分的重新组织。尽管普瑞特罗和IPR在腮腺中引起相当相似的结构变化,但已注意到这两种药物对腺体生物化学的影响存在显著差异。显然,参与分泌活动的不同生化途径在对亚微观结构的影响方面具有共同作用。